102 related articles for article (PubMed ID: 17483377)
21. The balance shift in Th1/Th2 related IL-12/IL-5 cytokines in Graves' disease during methimazole therapy.
Molnár I
Autoimmunity; 2007 Feb; 40(1):31-7. PubMed ID: 17364495
[TBL] [Abstract][Full Text] [Related]
22. [Graves' disease].
Radetti G; Rigon F; Tatò L; Tonini G; Bernasconi S; Bona G; Bozzola M; Buzi F; de Santis C; De Sanctis V
Minerva Pediatr; 1997 Nov; 49(11):545-7. PubMed ID: 9549300
[No Abstract] [Full Text] [Related]
23. [Update on endocrine orbitopathy].
Ponto KA; Kahaly GJ; Pitz S
Klin Monbl Augenheilkd; 2009 Feb; 226(2):R13-28; quiz R29-31. PubMed ID: 19206039
[No Abstract] [Full Text] [Related]
24. [Etiology and treatment of Graves' disease (some problems)].
Werner SC
Nord Med; 1968 Dec; 80(49):1645-50. PubMed ID: 4191771
[No Abstract] [Full Text] [Related]
25. Comparison of single daily dose of methimazole and propylthiouracil in the treatment of Graves' hyperthyroidism.
He CT; Hsieh AT; Pei D; Hung YJ; Wu LY; Yang TC; Lian WC; Huang WS; Kuo SW
Clin Endocrinol (Oxf); 2004 Jun; 60(6):676-81. PubMed ID: 15163329
[TBL] [Abstract][Full Text] [Related]
26. A 6-year follow-up of a randomized prospective trial comparing methimazole treatment with or without exogenous L-thyroxine in Chinese patients with Graves' disease.
Liu X; Qiang W; Liu X; Liu L; Liu S; Gao A; Gao S; Shi B
Exp Clin Endocrinol Diabetes; 2014 Nov; 122(10):564-7. PubMed ID: 25140995
[TBL] [Abstract][Full Text] [Related]
27. [Current management of endocrine orbitopathy].
Ponto KA; Kahaly GJ
Med Klin (Munich); 2008 Oct; 103(10):717-30; quiz 729-30. PubMed ID: 18936897
[No Abstract] [Full Text] [Related]
28. Graves' disease: clinical pathophysiology, presentation and treatment options.
Holt K
J Pract Nurs; 2010; 60(3):13-8. PubMed ID: 21175104
[No Abstract] [Full Text] [Related]
29. Effects of chronic iodine administration on thyroid status in euthyroid subjects previously treated with antithyroid drugs for Graves' hyperthyroidism.
Roti E; Gardini E; Minelli R; Bianconi L; Salvi M; Gavaruzzi G; Braverman LE
J Clin Endocrinol Metab; 1993 Apr; 76(4):928-32. PubMed ID: 7682562
[TBL] [Abstract][Full Text] [Related]
30. Frequency of antineutrophil cytoplasmic antibody in Graves' disease patients treated with methimazole.
Gumà M; Salinas I; Reverter JL; Roca J; Valls-Roc M; Juan M; Olivé A
J Clin Endocrinol Metab; 2003 May; 88(5):2141-6. PubMed ID: 12727967
[TBL] [Abstract][Full Text] [Related]
31. [Effect of thyroxine upon prevention of recurrence of Graves' disease treated with antithyroid drugs].
Wu G; Jie Y; Situ Y
Zhonghua Yi Xue Za Zhi; 2001 Mar; 81(5):274-5. PubMed ID: 11798886
[TBL] [Abstract][Full Text] [Related]
32. Occurrence of ophthalmopathy after treatment for Graves' hyperthyroidism. The Thyroid Study Group.
Tallstedt L; Lundell G; Tørring O; Wallin G; Ljunggren JG; Blomgren H; Taube A
N Engl J Med; 1992 Jun; 326(26):1733-8. PubMed ID: 1489388
[TBL] [Abstract][Full Text] [Related]
33. [The effect of one-month antithyroid therapy on peripheral metabolism of reactive oxygen species in Graves' disease with infiltrative ophthalmopathy].
Bednarek J; Wysocki H; Sowiński J
Przegl Lek; 2004; 61(8):841-4. PubMed ID: 15789912
[TBL] [Abstract][Full Text] [Related]
34. The rationale for B lymphocyte depletion in Graves' disease. Monoclonal anti-CD20 antibody therapy as a novel treatment option.
El Fassi D; Nielsen CH; Hasselbalch HC; Hegedüs L
Eur J Endocrinol; 2006 May; 154(5):623-32. PubMed ID: 16645007
[TBL] [Abstract][Full Text] [Related]
35. [Graves' disease].
Illouz F; Rodien P
Rev Prat; 2014 Jun; 64(6):828-34. PubMed ID: 25090772
[TBL] [Abstract][Full Text] [Related]
36. High prevalence of antineutrophil cytoplasmic antibody positivity in childhood onset Graves' disease treated with propylthiouracil.
Sato H; Hattori M; Fujieda M; Sugihara S; Inomata H; Hoshi M; Miyamoto S
J Clin Endocrinol Metab; 2000 Nov; 85(11):4270-3. PubMed ID: 11095466
[TBL] [Abstract][Full Text] [Related]
37. A case of bilateral breast cancer and Graves' disease.
Benedetti M; Tinozzi FP; Albertario S; Bianchi C; Niebel T; Vailati A; Danova M; Tinozzi S
Tumori; 2004; 90(5):504-6. PubMed ID: 15656338
[TBL] [Abstract][Full Text] [Related]
38. Combination therapy of chloroquine and methimazole in Graves' disease: a pilot randomized controlled trial.
Soltani A; Moayyeri A; Azizi F
Biomed Pharmacother; 2007 May; 61(4):241-3. PubMed ID: 17462854
[No Abstract] [Full Text] [Related]
39. Methimazole has no dose-related effect on the intensity of the intrathyroidal autoimmune process in relapsing Graves' disease.
Paschke R; Vogg M; Kristoferitsch R; Aktuna D; Wawschinek O; Eber O; Usadel KH
J Clin Endocrinol Metab; 1995 Aug; 80(8):2470-4. PubMed ID: 7629244
[TBL] [Abstract][Full Text] [Related]
40. Effect of methimazole, with or without L-thyroxine, on remission rates in Graves' disease.
Rittmaster RS; Abbott EC; Douglas R; Givner ML; Lehmann L; Reddy S; Salisbury SR; Shlossberg AH; Tan MH; York SE
J Clin Endocrinol Metab; 1998 Mar; 83(3):814-8. PubMed ID: 9506733
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
